{
 "PrintNo":"A10193","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2024-05-10T10:51:58.827513Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-05-10","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2024-05-10","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":1461,"Name":"Keith Brown","Short":"BROWN K"}],
 "Title":"Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists",
 "Summary":"Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.",
 "LawSection":"Public Health Law",
 "LawCode":"Amd §3309, Pub Health L; amd §§19.09, 36.01 & 25.18, Ment Hyg L; amd §6908, Ed L; amd §2617, Ins L",
 "ActClause":"AN ACT to amend the public health law, the mental hygiene law, the education law and the insurance law, in relation to including all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists"
}